CAMBRIDGE, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) — ConverGene is pleased to announce that it has entered into a collaboration with The
ConverGene Poster On First-In-Class Dual Beti/DRD2 at AACR enthusiastically received at AACR Weds April 6, 2017. See the Poster.
CAMBRIDGE, Md., April 05, 2017 (GLOBE NEWSWIRE) — ConverGene has entered into a Collaborative Research and Development Agreement (CRADA)
with University of Maryland, Baltimore to Evaluate First-in-class Anti-cancer Agents
with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health. Under this agreement,